What is PYRILAMINE MALEATE used for?

PYRILAMINE MALEATE is indicated for Menstrual Cramps, Bloating, Water Weight Gain, Headache, Backache.

What development phase is PYRILAMINE MALEATE in?

PYRILAMINE MALEATE is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

PYRILAMINE MALEATE

FDA-approved approved Small molecule Quality 16/100

Pyrilamine Maleate is a marketed drug primarily indicated for menstrual cramps, with a key composition patent expiring in 2028. Its market position is bolstered by its established presence and specific indication, which may offer a niche advantage. The primary risk is the patent expiry in 2028, which could lead to increased competition from generics.

At a glance

Generic name	PYRILAMINE MALEATE
Drug class	Central Nervous System Stimulant [EPC]
Modality	Small molecule
Phase	FDA-approved
First approval	1973

Approved indications

Menstrual Cramps
Bloating
Water Weight Gain
Headache
Backache
Muscle Aches
Fatigue

Common side effects

No common side effects on file.

Key clinical trials

Efficacy and Safety of Pediatric Drugs in Nasal Congestion (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PYRILAMINE MALEATE CI brief — competitive landscape report
PYRILAMINE MALEATE updates RSS · CI watch RSS